A carregar...
Omadacycline Enters the Ring: A New Antimicrobial Contender
Omadacycline is a novel aminomethylcycline approved for the treatment of community‐acquired bacterial pneumonia and acute bacterial skin and skin structure infections. This article reviews existing data pertaining to the biochemistry, mechanism of action, pharmacokinetics/pharmacodynamics, in vitro...
Na minha lista:
| Publicado no: | Pharmacotherapy |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6587716/ https://ncbi.nlm.nih.gov/pubmed/30290000 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/phar.2185 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|